Conflicting Roles of Mismatch and Nucleotide Excision Repair in Cellular Susceptibility to Anticancer Drugs

This publication has 108 references indexed in Scilit:

• hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents
  Oncogene, 1997
• Cytotoxic Mechanism of 6-Thioguanine: hMutSα, the Human Mismatch Binding Heterodimer, Binds to DNA Containing S⁶-Methylthioguanine
  Biochemistry, 1997
• Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification
  Cancer Letters, 1996
• Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over
  Nature Genetics, 1996
• Induction of UV-Damage Recognition Protein by Cisplatin Treatment
  Biochemistry, 1995
• Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients
  European Journal Of Cancer, 1994
• A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif
  Nature, 1990
• Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II)
  Chemico-Biological Interactions, 1988
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation
  Biochemistry, 1985
• Cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cells
  Biochemical and Biophysical Research Communications, 1983